DalsnaFinance

LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use

Markets PR Newswire By PR Newswire 22 Jun 2026 00:00 1 min read
LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use

INCHEON, South Korea and SAN DIEGO, June 21, 2026 /PRNewswire/ -- LOTTE Biologics announced that it has completed major construction and obtained approval for use for Plant 1 at its Songdo Bio Campus in Incheon, South Korea. The milestone was achieved approximately two years after the...

INCHEON, South Korea and SAN DIEGO, June 21, 2026 /PRNewswire/ -- LOTTE Biologics announced that it has completed major construction and obtained approval for use for Plant 1 at its Songdo Bio Campus in Incheon, South Korea. The milestone was achieved approximately two years after the...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.